A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and Ii Hereditary Angioedema in the Uk Setting

Sorrel E. Wolowacz; Isobel Victoria Pearson; M Helbert; F Pang; M Alvarez-Reyes; Isobel Victoria Pearson; Sorrel E. Wolowacz; L Diwakar

A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and Ii Hereditary Angioedema in the Uk Setting

Helbert, M., Pang, F., Alvarez-Reyes, M., Pearson, I., Wolowacz, S., & Diwakar, L. (2012). A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and Ii Hereditary Angioedema in the Uk Setting. Value in Health, 15(7), A513-A513.

Copy citation

Recent Publications

Article

The early motor questionnaire facilitates the remote assessment of normative motor development in infancy and toddlerhood

January 01, 2025

Article

A Cost-Effectiveness Comparison of Icatibant and C1-Esterase Inhibitor Concentrate for the Symptomatic Treatment of Acute Attacks of Types I and Ii Hereditary Angioedema in the Uk Setting

Recent Publications

The early motor questionnaire facilitates the remote assessment of normative motor development in infancy and toddlerhood

Adult vaccination coverage in the United States

Implementing law enforcement-based victim services

Dengue and diabetes comorbidity